This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Free Online Activities

What Clinicians Need to Know About Neuroprotective Issues in Bipolar Disorder

Vladimir Maletic, MD

Published: December 4, 2007

This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders


Article Abstract

Neuroimaging and pathohistologic research may show whether bipolar disorder is a degenerative and progressive condition, if detectable changes in the brain record past occurrences, and whether these changes are reversible. Interpreting neuroimaging studies has been complicated by a lack of identification of patient mood states and differences in patients’ medication status, but several observations have been made. Pathohistologic research suggests that bipolar disorder is associated with significant cell pathology.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 68

Quick Links: Bipolar Disorder

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Effect of Zuranolone on Concurrent Anxiety and Insomnia Symptoms in Women With Postpartum Depression

Zuranolone was associated with improvements in depressive and anxiety symptoms and was beneficial for insomnia and patient-perceived...

Read More...